Publication | Closed Access

Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months

VaccinationCervical CancerHuman Papillomavirus VaccinesHpv VaccinationPrecision VaccinologyAntibody ResponseVaccine EfficacyPublic HealthVaccine HesitancyMedicineThree-dose Schedule